San Diego, CA — In a development that could herald a novel adjunct to conventional cancer therapies, interim clinical data…
Read More
Small study suggests probiotic yogurt strain may boost immunotherapy response in lung cancer
The global oncology community converged at the American Association for Cancer Research (AACR) 2026 Annual Meeting in San Diego, a…
Read More
CDC Testing Pause Puts Clinical Labs at the Center of Public Health Response
A temporary suspension of infectious disease testing services at the Centers for Disease Control and Prevention (CDC) has initiated a…
Read MoreSmall study suggests probiotic yogurt strain may boost immunotherapy response in lung cancer
The landscape of cancer treatment has been profoundly reshaped by immunotherapy, offering renewed hope and significantly improved prognoses for patients,…
Read More
Brain Immune System Response Linked to Early Loss of Smell in Alzheimer’s Disease Patients
The decline of the olfactory sense has long been observed as a precursor to the cognitive deterioration associated with Alzheimer’s…
Read More
Small study suggests probiotic yogurt strain may boost immunotherapy response in lung cancer
The landscape of lung cancer treatment has undergone a profound transformation with the advent of immunotherapy, offering renewed hope and…
Read More
UC San Francisco Researchers Identify Biological Link Between Gut Immune Response and Brain-Mediated Appetite Loss
In a breakthrough study that bridges the gap between immunology and neuroscience, researchers at the University of California, San Francisco…
Read More
Small Study Suggests Probiotic Yogurt Strain May Boost Immunotherapy Response in Lung Cancer
The landscape of lung cancer treatment has undergone a significant transformation with the advent of immunotherapy, offering renewed hope and…
Read More
Immune System Response in the Brain Identified as Primary Cause for Early Olfactory Loss in Alzheimer’s Disease
A groundbreaking study conducted by researchers at the German Center for Neurodegenerative Diseases (DZNE) and Ludwig-Maximilians-Universität München (LMU) has revealed…
Read More
FDA Issues Complete Response Letter to Replimune’s RP1 for Advanced Melanoma
The U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding Replimune Group’s Biologics License Application…
Read More
